Topotecan Recruiting Phase 2 Trials for Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Recurrent Fallopian Tube Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02312245Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer